Page last updated: 2024-11-04

tazarotene and Cicatrization

tazarotene has been researched along with Cicatrization in 1 studies

tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.

Cicatrization: The formation of fibrous tissue in the place of normal tissue during the process of WOUND HEALING. It includes scar tissue formation occurring in healing internal organs as well as in the skin after surface injuries.

Research Excerpts

ExcerptRelevanceReference
"By contrast, median qualitative acne scar scores were the same for both treatment groups at baseline and did not significantly change following either treatment."6.90Topical Tazarotene Gel, 0.1%, as a Novel Treatment Approach for Atrophic Postacne Scars: A Randomized Active-Controlled Clinical Trial. ( Afra, TP; Dogra, S; Kumar, A; Narang, T; Razmi T, M, 2019)
"By contrast, median qualitative acne scar scores were the same for both treatment groups at baseline and did not significantly change following either treatment."2.90Topical Tazarotene Gel, 0.1%, as a Novel Treatment Approach for Atrophic Postacne Scars: A Randomized Active-Controlled Clinical Trial. ( Afra, TP; Dogra, S; Kumar, A; Narang, T; Razmi T, M, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afra, TP1
Razmi T, M1
Narang, T1
Dogra, S1
Kumar, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Microneedling Versus Topical Tazarotene 0.1% Gel for the Treatment of Atrophic Post Acne Scarring - a Randomized Controlled Study[NCT03170596]36 participants (Actual)Interventional2017-06-02Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for tazarotene and Cicatrization

ArticleYear
Topical Tazarotene Gel, 0.1%, as a Novel Treatment Approach for Atrophic Postacne Scars: A Randomized Active-Controlled Clinical Trial.
    JAMA facial plastic surgery, 2019, Mar-01, Volume: 21, Issue:2

    Topics: Acne Vulgaris; Administration, Topical; Adult; Atrophy; Cicatrix; Cosmetic Techniques; Dermatologic

2019